
Datar Cancer Genetics
Provider of cell-based and molecular genomic services intended for the domain of oncology. The company has a portfolio of tests with a deep pipeline of applications and services in cancer screening, d...
Valuation
$0
Share Price
N/A
Total Raised
$810K
Last Round
N/A